Trial in Progress: PROSERA, a Phase 3 Study of the Efficacy and Safety of Seralutinib in Adults with Pulmonary Arterial Hypertension (PAH)
Pneumologie | March 18, 2025 | Volume: 79 | Issue: No issue available | Pages: No page available
10.1055/s-0045-1804609